Search
Merck & Co Inc
MRKAdd to Watchlist
113.870USD
-1.550-1.34%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
281.24BMarket Cap
31.92P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Merck & Co Inc is 7.88, ranking 91 out of 157 in the Pharmaceuticals industry. The average price target is 102.50, with a high of 139.00 and a low of 82.00.
Analyst Rating
Based on
32
analysts
Buy
Current Rating
129.166
Target Price
+11.89%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
175
Total
6
Median
8
Average
Company name
Ratings
Analysts
Merck & Co Inc
MRK
32
Biogen Inc
BIIB
38
Amgen Inc
AMGN
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
1
2
3
...
35
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Merck & Co Inc's expected revenue for the next quarter?
Merck & Co Inc's expected revenue is 16.36B.
What is Merck & Co Inc's price target?
Analysts forecast that Merck & Co Inc's price target is USD 102.50, with the highest forecast at USD 139.00 and the lowest forecast at USD 82.00.
How have Merck & Co IncMRK's recent earnings per share performed?
The market expectation was USD -1.72, while Merck & Co IncMRK's earnings per share (EPS) for the previous quarter was USD 1.19. EPS for the next quarter is expected at USD 2.11.
What is the analyst rating for Merck & Co Inc?
Based on the ratings of Merck & Co Inc's stock from 32 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
